APA

Manzanedo I., Pereira F., Serrano Á., Pérez-Viejo E., Martínez-Torres B., Carrión L. & Calzas J. (20191226). The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Chicago

Manzanedo I, Pereira F, Serrano Á, Pérez-Viejo E, Martínez-Torres B, Carrión L and Calzas J. 20191226. The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Harvard

Manzanedo I., Pereira F., Serrano Á., Pérez-Viejo E., Martínez-Torres B., Carrión L. and Calzas J. (20191226). The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

MLA

Manzanedo I, Pereira F, Serrano Á, Pérez-Viejo E, Martínez-Torres B, Carrión L and Calzas J. The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 20191226.